Exposure to Polyhexamethylene Guanidine Exacerbates Bronchial Hyperresponsiveness and Lung Inflammation in a Mouse Model of Ovalbumin-Induced Asthma

Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in c...

Full description

Saved in:
Bibliographic Details
Published inAllergy, asthma & immunology research Vol. 13; no. 4; pp. 655 - 664
Main Authors Lee, Seung-Hwa, Ahn, Jae-Rin, Go, Han-Na, Lee, So-Yeon, Park, Min Jee, Song, Kun Baek, Yoon, Jisun, Jung, Sungsu, Cho, Hyun-Ju, Lee, Eun, Yang, Song-I, Hong, Soo-Jong
Format Journal Article
LanguageEnglish
Published Seoul Korean Academy of Asthma, Allergy and Clinical Immunology 01.07.2021
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
대한천식알레르기학회
Subjects
Online AccessGet full text
ISSN2092-7355
2092-7363
DOI10.4168/aair.2021.13.4.655

Cover

Loading…
Abstract Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma.
AbstractList Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma.Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma.
Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma. KCI Citation Count: 0
Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma.
Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma.
Author Park, Min Jee
Lee, So-Yeon
Lee, Seung-Hwa
Cho, Hyun-Ju
Yang, Song-I
Go, Han-Na
Song, Kun Baek
Yoon, Jisun
Jung, Sungsu
Lee, Eun
Ahn, Jae-Rin
Hong, Soo-Jong
AuthorAffiliation 5 Department of Pediatrics, International St. Mary's hospital, Catholic Kwandong University, Incheon, Korea
2 Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
7 Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea
4 Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea
3 Department of Pediatrics, Mediplex Sejong Hospital, Incheon, Korea
6 Department of Pediatrics, Chonnam National University College of Medicine, Gwangju, Korea
1 Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 6 Department of Pediatrics, Chonnam National University College of Medicine, Gwangju, Korea
– name: 4 Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea
– name: 1 Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea
– name: 7 Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea
– name: 3 Department of Pediatrics, Mediplex Sejong Hospital, Incheon, Korea
– name: 2 Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– name: 5 Department of Pediatrics, International St. Mary's hospital, Catholic Kwandong University, Incheon, Korea
Author_xml – sequence: 1
  givenname: Seung-Hwa
  orcidid: 0000-0001-9359-0318
  surname: Lee
  fullname: Lee, Seung-Hwa
  organization: Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 2
  givenname: Jae-Rin
  orcidid: 0000-0002-7653-3052
  surname: Ahn
  fullname: Ahn, Jae-Rin
  organization: Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Han-Na
  orcidid: 0000-0003-0730-5133
  surname: Go
  fullname: Go, Han-Na
  organization: Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 4
  givenname: So-Yeon
  orcidid: 0000-0002-2499-0702
  surname: Lee
  fullname: Lee, So-Yeon
  organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Min Jee
  orcidid: 0000-0003-0891-1311
  surname: Park
  fullname: Park, Min Jee
  organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Kun Baek
  orcidid: 0000-0001-6981-6292
  surname: Song
  fullname: Song, Kun Baek
  organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
– sequence: 7
  givenname: Jisun
  orcidid: 0000-0002-4904-9118
  surname: Yoon
  fullname: Yoon, Jisun
  organization: Department of Pediatrics, Mediplex Sejong Hospital, Incheon, Korea
– sequence: 8
  givenname: Sungsu
  orcidid: 0000-0002-0559-4982
  surname: Jung
  fullname: Jung, Sungsu
  organization: Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea
– sequence: 9
  givenname: Hyun-Ju
  orcidid: 0000-0003-4282-4000
  surname: Cho
  fullname: Cho, Hyun-Ju
  organization: Department of Pediatrics, International St. Mary's hospital, Catholic Kwandong University, Incheon, Korea
– sequence: 10
  givenname: Eun
  orcidid: 0000-0002-7462-0144
  surname: Lee
  fullname: Lee, Eun
  organization: Department of Pediatrics, Chonnam National University College of Medicine, Gwangju, Korea
– sequence: 11
  givenname: Song-I
  orcidid: 0000-0002-9648-4585
  surname: Yang
  fullname: Yang, Song-I
  organization: Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea
– sequence: 12
  givenname: Soo-Jong
  orcidid: 0000-0003-1409-2113
  surname: Hong
  fullname: Hong, Soo-Jong
  organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002737529$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9UstqGzEUHUpK82h-oCtBN-3C7ug1M9oU3OAmBpeUkq6FRroTK9FIrjRj7P_oB0e2Q6BZVAvdi3TO4XLuOS9OfPBQFB9wOWW4ar4oZeOUlARPMZ2yacX5m-KMlIJMalrRk5ee89PiMqWHMh-KGavYu-KUMoIJ5_is-DvfrkMaI6AhoJ_B7VawVT0Mq50DD-h6VN4am7v5VmmIrRogoW8xeL2yyqGb3RpihLQOPtlNZqSElDdoOfp7tPCdU32vBhs8sh4p9COMCfJtwKHQoduNcu3YWz9ZeDNqMGiWhlWv3hdvO-USXD7Xi-L39_nd1c1keXu9uJotJ5oxPEwoq4RQumpxrbmptWjBdKAV5mVXAnBjmo5WrAHBBanzozaCNGVb67ZjTd3Si-LzUdfHTj5qK4Oyh3of5GOUs193CykaRkvGMvbrEbse2x6MBj9E5eQ62l7F3YH574-3q6yzkU02OvudBT49C8TwZ4Q0yN4mDc4pD9kWSThrqGCC4wz9-Ar6EMbosxV7lKhJXuseRY4oHUNKEbqXYXAp9xmR-4zIfUYkppLJnJFMal6RtB0OG8pDW_c_6hPEecay
CitedBy_id crossref_primary_10_3389_fphar_2023_1114739
crossref_primary_10_3346_jkms_2022_37_e257
crossref_primary_10_1016_j_envpol_2024_124728
crossref_primary_10_3346_jkms_2022_37_e319
Cites_doi 10.1172/JCI10259
10.1016/j.fct.2014.04.027
10.1016/j.jaci.2004.11.017
10.1016/S0002-9440(10)61235-7
10.1289/ehp.10846
10.1007/s11882-017-0681-6
10.1126/science.282.5397.2261
10.1074/jbc.M208339200
10.1186/1465-9921-6-106
10.1111/j.1365-2222.2006.02586.x
10.1177/039463200802100105
10.1164/rccm.201805-0840LE
10.1378/chest.09-1895
10.1038/s41598-017-05654-w
10.1038/mi.2012.109
10.1056/NEJMoa1007302
10.1155/2010/318029
10.1084/jem.20080452
10.1007/s00204-006-0075-3
10.1007/s00204-015-1486-9
10.4168/aair.2020.12.1.86
10.1097/ACI.0b013e32830a7086
10.1177/039463200702000409
10.1038/icb.2009.101
10.4168/aair.2019.11.4.450
10.1172/JCI36130
10.1164/rccm.200308-1151OC
10.1111/j.0105-2896.2004.00210.x
10.1080/00039890109604447
10.1165/rcmb.2004-0273OC
10.1146/annurev.immunol.21.120601.141142
10.1111/j.1440-1843.2012.02195.x
10.1016/j.jaci.2005.08.057
10.1371/journal.pone.0151849
10.1378/chest.107.3.711
10.4168/aair.2020.12.6.934
10.1186/rr5
10.1016/j.cyto.2015.05.008
10.1097/ACI.0b013e3282f42696
10.4049/jimmunol.163.11.6321
10.1021/es300567j
10.1152/ajplung.00188.2013
10.1023/A:1015039328620
10.4168/aair.2012.4.3.150
10.1016/j.scitotenv.2017.10.237
ContentType Journal Article
Copyright Copyright Korean Academy of Asthma, Allergy and Clinical Immunology Jul 2021
Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.
Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease
Copyright_xml – notice: Copyright Korean Academy of Asthma, Allergy and Clinical Immunology Jul 2021
– notice: Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.
– notice: Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease
DBID AAYXX
CITATION
7T5
7U7
C1K
H94
7X8
5PM
ACYCR
DOI 10.4168/aair.2021.13.4.655
DatabaseName CrossRef
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


AIDS and Cancer Research Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-7363
EndPage 664
ExternalDocumentID oai_kci_go_kr_ARTI_9843044
PMC8255342
10_4168_aair_2021_13_4_655
GrantInformation_xml – fundername: ;
  grantid: NIER-SP2020-007
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAKDD
AAYXX
ACPRK
ADBBV
ADRAZ
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
C~G
DIK
DYU
E3Z
EF.
F5P
GX1
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
7T5
7U7
C1K
H94
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c441t-34699ac6b17c5d7c9bedfeca150f0ee5dd8f3648e9592750fcd9280b7cbf487b3
IEDL.DBID M48
ISSN 2092-7355
IngestDate Sun Mar 09 07:51:56 EDT 2025
Thu Aug 21 13:28:00 EDT 2025
Fri Jul 11 07:26:07 EDT 2025
Mon Jun 30 11:59:35 EDT 2025
Fri Jul 04 01:06:57 EDT 2025
Thu Apr 24 23:02:25 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-34699ac6b17c5d7c9bedfeca150f0ee5dd8f3648e9592750fcd9280b7cbf487b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6981-6292
0000-0002-7462-0144
0000-0002-9648-4585
0000-0002-0559-4982
0000-0003-4282-4000
0000-0002-2499-0702
0000-0001-9359-0318
0000-0003-0891-1311
0000-0002-7653-3052
0000-0003-1409-2113
0000-0003-0730-5133
0000-0002-4904-9118
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4168/aair.2021.13.4.655
PMID 34212551
PQID 2549727351
PQPubID 2048270
PageCount 10
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9843044
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8255342
proquest_miscellaneous_2548394951
proquest_journals_2549727351
crossref_primary_10_4168_aair_2021_13_4_655
crossref_citationtrail_10_4168_aair_2021_13_4_655
PublicationCentury 2000
PublicationDate 2021-07-01
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Seoul
PublicationPlace_xml – name: Seoul
PublicationTitle Allergy, asthma & immunology research
PublicationYear 2021
Publisher Korean Academy of Asthma, Allergy and Clinical Immunology
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
대한천식알레르기학회
Publisher_xml – name: Korean Academy of Asthma, Allergy and Clinical Immunology
– name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
– name: 대한천식알레르기학회
References Kasahara (10.4168/aair.2021.13.4.655_ref38) 2000; 106
Wynn (10.4168/aair.2021.13.4.655_ref45) 2003; 21
Gowers (10.4168/aair.2021.13.4.655_ref18) 2012; 17
Grünig (10.4168/aair.2021.13.4.655_ref43) 1998; 282
Folli (10.4168/aair.2021.13.4.655_ref10) 2008; 8
Puxeddu (10.4168/aair.2021.13.4.655_ref32) 2006; 117
Yoon (10.4168/aair.2021.13.4.655_ref7) 2018; 198
Bao (10.4168/aair.2021.13.4.655_ref41) 2015; 75
Kindstedt (10.4168/aair.2021.13.4.655_ref30) 2017; 7
Suda (10.4168/aair.2021.13.4.655_ref3) 1995; 107
Donaldson (10.4168/aair.2021.13.4.655_ref17) 2000; 1
Murphy (10.4168/aair.2021.13.4.655_ref8) 2010; 137
Koike (10.4168/aair.2021.13.4.655_ref21) 2008; 21
Ying (10.4168/aair.2021.13.4.655_ref27) 1999; 163
Spira (10.4168/aair.2021.13.4.655_ref39) 2004; 31
Mentink-Kane (10.4168/aair.2021.13.4.655_ref42) 2004; 202
Lee (10.4168/aair.2021.13.4.655_ref15) 2020; 12
Ege (10.4168/aair.2021.13.4.655_ref12) 2011; 364
Inoue (10.4168/aair.2021.13.4.655_ref20) 2006; 80
Kim (10.4168/aair.2021.13.4.655_ref6) 2016; 90
Shaw (10.4168/aair.2021.13.4.655_ref37) 2014; 6
Forbes (10.4168/aair.2021.13.4.655_ref44) 2010; 88
Bergeron (10.4168/aair.2021.13.4.655_ref9) 2010; 17
Jaakkola (10.4168/aair.2021.13.4.655_ref14) 2008; 116
Dorman (10.4168/aair.2021.13.4.655_ref28) 2005; 115
Lee (10.4168/aair.2021.13.4.655_ref4) 2012; 46
Bocchino (10.4168/aair.2021.13.4.655_ref29) 2002; 57
Park (10.4168/aair.2021.13.4.655_ref47) 2016; 11
Acevedo (10.4168/aair.2021.13.4.655_ref13) 2019; 11
Huaux (10.4168/aair.2021.13.4.655_ref34) 2005; 167
Junttila (10.4168/aair.2021.13.4.655_ref46) 2008; 205
Aleshina (10.4168/aair.2021.13.4.655_ref1) 2001; 33
Korea Centers for Disease Control and Prevention (10.4168/aair.2021.13.4.655_ref2) 2011; 4
Walters (10.4168/aair.2021.13.4.655_ref11) 2008; 8
Thompson (10.4168/aair.2021.13.4.655_ref25) 2001; 56
Shin (10.4168/aair.2021.13.4.655_ref35) 2014; 306
Jang (10.4168/aair.2021.13.4.655_ref24) 2012; 4
Draijer (10.4168/aair.2021.13.4.655_ref31) 2017; 17
Park (10.4168/aair.2021.13.4.655_ref48) 2018; 616-617
de Haar (10.4168/aair.2021.13.4.655_ref23) 2006; 36
Lin (10.4168/aair.2021.13.4.655_ref16) 2020; 12
Cosgrove (10.4168/aair.2021.13.4.655_ref36) 2004; 170
Song (10.4168/aair.2021.13.4.655_ref5) 2014; 69
Inoue (10.4168/aair.2021.13.4.655_ref19) 2005; 6
Isgrò (10.4168/aair.2021.13.4.655_ref33) 2013; 6
Barnes (10.4168/aair.2021.13.4.655_ref26) 2008; 118
Meyer (10.4168/aair.2021.13.4.655_ref40) 2002; 277
Inoue (10.4168/aair.2021.13.4.655_ref22) 2007; 20
References_xml – volume: 106
  start-page: 1311
  year: 2000
  ident: 10.4168/aair.2021.13.4.655_ref38
  publication-title: J Clin Invest
  doi: 10.1172/JCI10259
– volume: 69
  start-page: 267
  year: 2014
  ident: 10.4168/aair.2021.13.4.655_ref5
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2014.04.027
– volume: 4
  start-page: 817
  year: 2011
  ident: 10.4168/aair.2021.13.4.655_ref2
  publication-title: Public Health Wkly Rep
– volume: 115
  start-page: 501
  year: 2005
  ident: 10.4168/aair.2021.13.4.655_ref28
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2004.11.017
– volume: 167
  start-page: 1485
  year: 2005
  ident: 10.4168/aair.2021.13.4.655_ref34
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)61235-7
– volume: 116
  start-page: 845
  year: 2008
  ident: 10.4168/aair.2021.13.4.655_ref14
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.10846
– volume: 17
  start-page: 12
  year: 2017
  ident: 10.4168/aair.2021.13.4.655_ref31
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-017-0681-6
– volume: 282
  start-page: 2261
  year: 1998
  ident: 10.4168/aair.2021.13.4.655_ref43
  publication-title: Science
  doi: 10.1126/science.282.5397.2261
– volume: 277
  start-page: 45400
  year: 2002
  ident: 10.4168/aair.2021.13.4.655_ref40
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M208339200
– volume: 6
  start-page: 106
  year: 2005
  ident: 10.4168/aair.2021.13.4.655_ref19
  publication-title: Respir Res
  doi: 10.1186/1465-9921-6-106
– volume: 36
  start-page: 1469
  year: 2006
  ident: 10.4168/aair.2021.13.4.655_ref23
  publication-title: Clin Exp Allergy
  doi: 10.1111/j.1365-2222.2006.02586.x
– volume: 21
  start-page: 35
  year: 2008
  ident: 10.4168/aair.2021.13.4.655_ref21
  publication-title: Int J Immunopathol Pharmacol
  doi: 10.1177/039463200802100105
– volume: 198
  start-page: 1583
  year: 2018
  ident: 10.4168/aair.2021.13.4.655_ref7
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201805-0840LE
– volume: 137
  start-page: 1417
  year: 2010
  ident: 10.4168/aair.2021.13.4.655_ref8
  publication-title: Chest
  doi: 10.1378/chest.09-1895
– volume: 7
  start-page: 5334
  year: 2017
  ident: 10.4168/aair.2021.13.4.655_ref30
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-05654-w
– volume: 6
  start-page: 718
  year: 2013
  ident: 10.4168/aair.2021.13.4.655_ref33
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2012.109
– volume: 364
  start-page: 701
  year: 2011
  ident: 10.4168/aair.2021.13.4.655_ref12
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1007302
– volume: 17
  start-page: e85
  year: 2010
  ident: 10.4168/aair.2021.13.4.655_ref9
  publication-title: Can Respir J
  doi: 10.1155/2010/318029
– volume: 205
  start-page: 2595
  year: 2008
  ident: 10.4168/aair.2021.13.4.655_ref46
  publication-title: J Exp Med
  doi: 10.1084/jem.20080452
– volume: 80
  start-page: 614
  year: 2006
  ident: 10.4168/aair.2021.13.4.655_ref20
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-006-0075-3
– volume: 90
  start-page: 617
  year: 2016
  ident: 10.4168/aair.2021.13.4.655_ref6
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-015-1486-9
– volume: 12
  start-page: 86
  year: 2020
  ident: 10.4168/aair.2021.13.4.655_ref15
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2020.12.1.86
– volume: 8
  start-page: 367
  year: 2008
  ident: 10.4168/aair.2021.13.4.655_ref10
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/ACI.0b013e32830a7086
– volume: 20
  start-page: 737
  year: 2007
  ident: 10.4168/aair.2021.13.4.655_ref22
  publication-title: Int J Immunopathol Pharmacol
  doi: 10.1177/039463200702000409
– volume: 88
  start-page: 240
  year: 2010
  ident: 10.4168/aair.2021.13.4.655_ref44
  publication-title: Immunol Cell Biol
  doi: 10.1038/icb.2009.101
– volume: 11
  start-page: 450
  year: 2019
  ident: 10.4168/aair.2021.13.4.655_ref13
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2019.11.4.450
– volume: 118
  start-page: 3546
  year: 2008
  ident: 10.4168/aair.2021.13.4.655_ref26
  publication-title: J Clin Invest
  doi: 10.1172/JCI36130
– volume: 6
  start-page: 1532
  year: 2014
  ident: 10.4168/aair.2021.13.4.655_ref37
  publication-title: J Thorac Dis
– volume: 170
  start-page: 242
  year: 2004
  ident: 10.4168/aair.2021.13.4.655_ref36
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200308-1151OC
– volume: 202
  start-page: 191
  year: 2004
  ident: 10.4168/aair.2021.13.4.655_ref42
  publication-title: Immunol Rev
  doi: 10.1111/j.0105-2896.2004.00210.x
– volume: 56
  start-page: 234
  year: 2001
  ident: 10.4168/aair.2021.13.4.655_ref25
  publication-title: Arch Environ Health
  doi: 10.1080/00039890109604447
– volume: 31
  start-page: 601
  year: 2004
  ident: 10.4168/aair.2021.13.4.655_ref39
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2004-0273OC
– volume: 21
  start-page: 425
  year: 2003
  ident: 10.4168/aair.2021.13.4.655_ref45
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.21.120601.141142
– volume: 57
  start-page: 17
  year: 2002
  ident: 10.4168/aair.2021.13.4.655_ref29
  publication-title: Allergy
– volume: 17
  start-page: 887
  year: 2012
  ident: 10.4168/aair.2021.13.4.655_ref18
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2012.02195.x
– volume: 117
  start-page: 103
  year: 2006
  ident: 10.4168/aair.2021.13.4.655_ref32
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.08.057
– volume: 11
  start-page: e0151849
  year: 2016
  ident: 10.4168/aair.2021.13.4.655_ref47
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0151849
– volume: 107
  start-page: 711
  year: 1995
  ident: 10.4168/aair.2021.13.4.655_ref3
  publication-title: Chest
  doi: 10.1378/chest.107.3.711
– volume: 12
  start-page: 934
  year: 2020
  ident: 10.4168/aair.2021.13.4.655_ref16
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2020.12.6.934
– volume: 1
  start-page: 12
  year: 2000
  ident: 10.4168/aair.2021.13.4.655_ref17
  publication-title: Respir Res
  doi: 10.1186/rr5
– volume: 75
  start-page: 25
  year: 2015
  ident: 10.4168/aair.2021.13.4.655_ref41
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2015.05.008
– volume: 8
  start-page: 39
  year: 2008
  ident: 10.4168/aair.2021.13.4.655_ref11
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/ACI.0b013e3282f42696
– volume: 163
  start-page: 6321
  year: 1999
  ident: 10.4168/aair.2021.13.4.655_ref27
  publication-title: J Immunol
  doi: 10.4049/jimmunol.163.11.6321
– volume: 46
  start-page: 2498
  year: 2012
  ident: 10.4168/aair.2021.13.4.655_ref4
  publication-title: Environ Sci Technol
  doi: 10.1021/es300567j
– volume: 306
  start-page: L620
  year: 2014
  ident: 10.4168/aair.2021.13.4.655_ref35
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00188.2013
– volume: 33
  start-page: 421
  year: 2001
  ident: 10.4168/aair.2021.13.4.655_ref1
  publication-title: Fibre Chem
  doi: 10.1023/A:1015039328620
– volume: 4
  start-page: 150
  year: 2012
  ident: 10.4168/aair.2021.13.4.655_ref24
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2012.4.3.150
– volume: 616-617
  start-page: 855
  year: 2018
  ident: 10.4168/aair.2021.13.4.655_ref48
  publication-title: Sci Total Environ
  doi: 10.1016/j.scitotenv.2017.10.237
SSID ssj0000314464
Score 2.2625995
Snippet Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been...
SourceID nrf
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 655
SubjectTerms Asthma
Brief Communication
Bronchus
Chemokines
Cytokines
Disinfectants
Epithelium
Exposure
Fibrosis
Guanidine
Health risks
Hypersensitivity
Immunoglobulin E
Inflammation
Inhalation
Lung diseases
Lungs
Ovalbumin
Pigment epithelium-derived factor
Respiration
Respiratory tract diseases
내과학
Title Exposure to Polyhexamethylene Guanidine Exacerbates Bronchial Hyperresponsiveness and Lung Inflammation in a Mouse Model of Ovalbumin-Induced Asthma
URI https://www.proquest.com/docview/2549727351
https://www.proquest.com/docview/2548394951
https://pubmed.ncbi.nlm.nih.gov/PMC8255342
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002737529
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Allergy, 2021, Asthma & Immunology Research, 13(4), , pp.655-664
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIlW9VDzFQqkM4oYS1nGcxwlVaKstYoEDK5WTZTt2N2pw2t0U7f4PfjAzSXZFJODAKYfYeXjGnu-LJ_MR8jpLGHPapEEB0SWII5MEWkdZoJhSIlFZXrRyb7NPyXQef7gUl3tkK3fUD-Dqj9QO9aTmyypc327ewYQH_BoCnMjeKlViZc-IhYyHcZgIsU_uQWRKkIzNerjfrswc2Q9uNEfjHIAlxNruP5q_XOaIHHLcMRWCDcLWvl-6ASId5lP-FqDO75PjHlnSs84VHpA96x-Sw1m_d_6I_Jysb2r8Hkibmn6pq83CrhUKSG8g8FgKvuJLCGSWTtbKwGAjCKXA0j1mQ1d0CoQVhTzajNpuhaTKF_QjrBb0wjvwrO4vSFp6quisvltZikprFa0d_fyjzYMufYBaIcYW9GzVLL6rx2R-Pvn6fhr0mgyBAeDUBBzodK5MollqRJGaXNvCWaMAV7qxtaIoMseTOLO5yLF0vDNFHmVjnRrtgBtp_oQc-Nrbp4S6GNCqdmmmIri2ijQHKGVTrlgOdF_EI8K2Qy5NX7AcdTMqCcQFLSbRYhItJhmXsQSLjcibXZ-brlzHP1u_AkvKa1NKrLKNx6taXi8lcIkLmWcxH8fwGCdbQ8ute0qk1Yj8BBuRl7vTMDNxu0V5C2OMbQB9AgGFNunAQXaPhncdnvHloq3xDcRdgO89---ez8kRvmuXWXxCDprlnX0B-KnRp8Acvs1P26nxC1XcHQo
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exposure+to+Polyhexamethylene+Guanidine+Exacerbates+Bronchial+Hyperresponsiveness+and+Lung+Inflammation+in+a+Mouse+Model+of+Ovalbumin-Induced+Asthma&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Lee%2C+Seung-Hwa&rft.au=Ahn%2C+Jae-Rin&rft.au=Go%2C+Han-Na&rft.au=Lee%2C+So-Yeon&rft.date=2021-07-01&rft.pub=The+Korean+Academy+of+Asthma%2C+Allergy+and+Clinical+Immunology%3B+The+Korean+Academy+of+Pediatric+Allergy+and+Respiratory+Disease&rft.issn=2092-7355&rft.eissn=2092-7363&rft.volume=13&rft.issue=4&rft.spage=655&rft.epage=664&rft_id=info:doi/10.4168%2Faair.2021.13.4.655&rft_id=info%3Apmid%2F34212551&rft.externalDocID=PMC8255342
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon